Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Individual differences in average evoked responses to d- and l-amphetamine with and without lithium carbonate in depressed patients

  • 29 Accesses

  • 23 Citations

Abstract

Visual average evoked responses (AERs) to four intensities of light were studied in hospitalized depressed patients receiving placebo, d-amphetamine, l-amphetamine, lithium and d- and l-amphetamine combined with lithium. For the assessment of the subjective effects of the drugs, the patients completed a 34-item mood and behavior self-rating scale. AER responses to repeated doses of the amphetamines were consistent within the same individual but varied greatly between different individuals. For the patient group considered as a whole, only minor AER changes occurred in response to either d- or l-amphetamine; nonetheless, these minor changes were attenuated by lithium co-administration. There were indications, however, that AER baseline measures could be used as predictors of change in self-rating due to both d-and l-amphetamine, as patients who had larger AER amplitudes on baseline also tended to have larger increases in activation ratings and reductions in depression ratings. The amount of increase in AER amplitude or amplitude/intensity slope seen with amphetamine was also significantly correlated with the amount of increase in activation or euphoria ratings with amphetamine administration. These effects were most prominent in the same P100 component that we have previously found to differentiate bipolar and unipolar depressed patient groups.

This is a preview of subscription content, log in to check access.

References

  1. Alles, G. A.: Comparative actions of optically isomeric phenisopropylamines. J. Pharmacol. exp. Ther. 66, 1 (1939)

  2. Baron, M., Gershon, E. S., Rudy, V., Jonas, W. Z., Buchsbaum, M.: Lithium response in depression as predicted by unipolar/bipolar illness, average evoked response, and COMT and family history. Arch. gen. Psychiat. 32, 1107–1111 (1975)

  3. Buchsbaum, M.: Average evoked response and stimulus intensity in identical and fraternal twins. Physiol. Psychol. 2, 365–370 (1974)

  4. Buchsbaum, M.: Self regulation of stimulus intensity: Augmenting/reducing and the average evoked response. In: Consciousness and self regulations, G. Schwartz and D. Shapiro, eds., pp. 101–135. New York: Plenum Press 1976

  5. Buchsbaum, M., Goodwin, F., Murphy, D. L., Borge, G.: AER in affective disorders. Amer. J. Psychiat. 128, 19–25 (1971)

  6. Buchsbaum, M., Landau, S., Murphy, D. L., Goodwin, F.: Average evoked response in bipolar and unipolar affective disorders: Relationship to sex, age of onset and monoamine oxidase. Biol. Psychiat. 7, 199–212 (1973)

  7. Buchsbaum, M., Wender, P.: Average evoked responses in normal and minimally brain dysfunctioned children treated with amphetamine. Arch. gen. Psychiat. 29, 764–770 (1973)

  8. Bunney, B. S., Walters, J. R., Kuhar, M. J., Roth, R. H., Aghajanian, G. K.: D- and L-amphetamine stereoisomers: Comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons. Psychopharm. Commun. 1, 177–190 (1975)

  9. Bunney, W. E., Jr., Hamburg, D. A.: Methods for reliable longitudinal observation of behavior. Arch. gen. Psychiat. 9, 280–294 (1963)

  10. Davis, C., Sanger, D. J., Steinberg, H., Tomkiewicz, M., U'Prichard, D. C.: Lithium and alphamethylparatyrosine prevent “manic” activity in rodents. Psychopharmacologia (Berl.) 36, 263–274 (1974)

  11. d'Encarnacao, P. S., Anderson, K.: Effects of lithium pretreatment on amphetamine and DMI/tetrabenazine produced psychomotor behavior. Dis. nerv. Syst. 31, 494–496 (1970)

  12. Ernst, A. M., Smelik, P. G.: Site of action of dopamine and apomorphine on compulsive gnawing behavior in rats. Experientia (Basel) 22, 837–838 (1966)

  13. Fawcett, J., Maas, J. W.: Depression and MHPG excretion. Response to dextroamphetamine and tricyclic antidepressants. Arch. gen. Psychiat. 26, 246–251 (1972)

  14. Fawcett, J., Siomopoulos, V.: Dextroamphetamine response as a possible predictor of improvement with tricyclic therapy in depression. Arch. gen. Psychiat. 25, 247–255 (1971)

  15. Ferris, R. M., Tang, E. L. M., Maxwell, R. H.: A comparison of the capacities of isomers of amphetamine, deoxypipradol, and methylphenidate to inhibit the uptake of tritiated catecholamine into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. J. Pharmacol. exp. Ther. 181, 407–416 (1972)

  16. Gillin, J. C., van Kammen, D. P., Murphy, D. L., Graves, J.: Differential effects of d- and l-amphetamine on the sleep of depressed patients: Unaffected by lithium carbonate. Life Sci. 17, 1233–1240 (1975)

  17. Harris, J. E., Baldessarini, R. J.: Uptake of [3H]-catecholamines by homogenates of rat corpus striatum and cerebral cortex: Effects of amphetamine analogues. Neuropharmacology 12, 669–679 (1973)

  18. Henry, G. M., Buchsbaum, M., Murphy, D. L.: Intravenous L-Dopa plus carbidopa in depressed patients: Average evoked response, learning and behavioral changes. Psychosom. Med. 38, 95–105 (1976)

  19. Hurst, P. M., Weidner, M. F., Radlow, R., Ross, S.: Drugs and placebos: Drug guessing by normal volunteers. Psychol. Rep. 33, 683–694 (1973)

  20. Jori, A., Monti, E.: Different sensitivity to drugs eliciting homovanillic acid increase in two strains of mice. J. Pharm. Pharmacol. 26, 993–994 (1974)

  21. Katz, R. I., Chase, T. N., Kopin, I. J.: Evoked release of norepinephrine and serotonin from brain slices: Inhibition by lithium. Science 162, 466–467 (1968)

  22. Kiloh, L. G., Neilson, M., Andrews, G.: Response of depressed patients to methylamphetamine. Brit. J. Psychiat. 125, 496–499 (1974)

  23. Kooi, K. A., Bagchi, B. K.: Observations on early components of the visual evoked response and occipital rhythms. Electroenceph. clin. Neurophysiol 17, 638–643 (1964)

  24. Maugh, T. H.: Medium size computers: Bringing computers into the lab. Science 182, 270–272 (1973)

  25. Murphy, D. L., Beigel, A., Weingartner, H., Bunney, W. E., Jr.: The quantification of manic behavior. In: Modern problems in pharmacopsychiatry, vol. 7, P. Pichot, ed., pp. 203–220. Basel: Karger 1974

  26. Murphy, D. L., Belmaker, R., Wyatt, R. J.: Monoamine oxidase in schizophrenia and other behavioral disorders. J. psychiat. Res. 11, 221–247 (1974)

  27. Murphy, D. L., Miller, H., Alterman, I., Weingartner, H.: Quantitative behavioral assessment of patients with affective illness. (In preparation)

  28. Redmond, D. E., Borge, G. F., Buchsbaum, M., Maas, J. W.: Evoked potential studies of brain catecholamine alterations in monkeys. J. psychiat. Res. 12, 97–116 (1975)

  29. Richey, E. T., Kooi, K. A., Waggoner, R. W.: Visually evoked responses in migraine. Electroenceph. clin. Neurophysiol. 21, 23–27 (1966)

  30. Roberts, J. M.: Prognostic factors in the electroshock treatment of depressive states. J. ment. Sci. 105, 703–713 (1959)

  31. Rudolf, G. deM.: The treatment of depression with methylamphetamine. J. ment. Sci. 102, 358–363 (1956)

  32. Saletu, B., Saletu, M., Itil, T. M., Coffin, C.: Effect of stimulatory drugs on the somatosensory evoked potential in man. Pharmakopsychiat. Neuropsychopharmak. 5, 129–136 (1972)

  33. Samson, H. H., Young, M. L.: The relation of flash intensity and background illumination to the photic evoked potential in the pigeon's optic tectum. Vision Res. 13, 253–261 (1973)

  34. Schou, M.: Lithium in psychiatric therapy and prophylaxis. J. psychia. Neuropsychopharmak 5, 129–136 (1972)

  35. Shagass, C.: Evoked potentials in psychiatry, p. 43. New York: Plenum Press 1972

  36. Shagass, C., Schwartz, M., Amadeo, M.: Some drug effects on evoked cerebral potentials in man. J. Neuropsychiat. 3, 49–59 (1962)

  37. Shagass, C., Schwartz, M., Krishnamoorti, S.: Some psychologic correlates of cerebral responses evoked by light flash. J. psychosom. Res. 9, 223–231 (1965)

  38. Simon, S. L., Taube, H.: A preliminary study on the use of methedrine in psychiatric diagnosis. J. nerv. ment. Dis. 104, 593–596 (1946)

  39. Small, J. G., Small, I. F.: Pharmacology-neurophysiology of lithium. In: Lithium, S. Gershon and B. Shopsin, eds., pp. 83–106. New York: Plenum Press 1973

  40. Snyder, S. H.: Putative neurotransmitters in the brain: Selective neuronal uptake, subcellular localization, and interactions with centrally acting drugs. Biol. Psychiat. 2, 367–389 (1970)

  41. Soskis, D., Shagass, C.: Evoked potential tests of augmenting/reducing. Psychophysiology 11, 175–190 (1974)

  42. Spilker, B., Callaway, E.: Effects of drugs on “augmenting/reducing” in averaged visual evoked responses in man. Psychopharmacologia (Berl.) 15, 116–121 (1969)

  43. Steinberg, H.: Animal models for behavioral and biochemical studies on the effects of lithium salt. Biochem. Soc. Transact. 1, 38–41 (1974)

  44. Taylor, K. M., Snyder, S. H.: Amphetamine differentiation by d- and l-isomers of behavior involving brain norepinephrine or dopamine. Science 168, 1487–1489 (1970)

  45. Tecce, J. J., Cole, J. O.: Amphetamine effects in man: Paradoxical drowsiness and lowered electrical brain activity. Science 185, 451–453 (1974)

  46. Thornburg, J. E., Moore, K. E.: Dopamine and norepinephrine uptake by rat brain synaptosomes: Relative inhibition potencies of l- and d-amphetamine and amantadine. Res. Commun. Chem. Path. Pharmacol. 5, 81–89 (1973)

  47. van Kammen, D. P., Murphy, D. L.: Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia (Berl.) 44, 215–224 (1975)

  48. Weingartner, H., van Kammen, D. P., Murphy, D. L.: Amphetamine effects on storage and retrieval in depressed patients. Presented at the American Psychological Association Annual Meeting, Chicago 1975

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Buchsbaum, M.S., Van Kammen, D.P. & Murphy, D.L. Individual differences in average evoked responses to d- and l-amphetamine with and without lithium carbonate in depressed patients. Psychopharmacology 51, 129–135 (1977). https://doi.org/10.1007/BF00431728

Download citation

Key words

  • Average evoked response
  • Amphetamine
  • Lithium
  • Affective illness